Latest stories

  • in

    Piramal Pharma gets USFDA EIR for Sellersville facility

    Mumbai: Piramal Pharma has recently announced that the US Food and Drug Administration (USFDA) has successfully concluded the inspection of the company’s manufacturing facility located at Sellersville, USA and has issued an Establishment Inspection Report (EIR) for the said facility. EIR is the final inspection report of an FDA inspection. The inspection was held between December 19, […] More

  • in

    Piramal Pharma Digwal facility successfully concludes USFDA inspection

    Mumbai: Piramal Pharma Limited has recently announced that the US Food and Drug Administration (USFDA) has successfully completed the Good Manufacturing Practices (GMP) inspection with Zero Form – 483 observations at the company’s Digwal facility. An FDA Form 483 is issued to firm management at the conclusion of an inspection when an investigator(s) has observed […] More